141 related articles for article (PubMed ID: 31055699)
1. Expression and clinical significance of SNAI1 and ZEB1 genes in acute myeloid leukemia patients.
Shousha WG; Ramadan SS; El-Saiid AS; Abdelmoneim AE; Abbas MA
Mol Biol Rep; 2019 Aug; 46(4):4625-4630. PubMed ID: 31055699
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium.
Lee JG; Jung E; Heur M
J Biol Chem; 2018 Mar; 293(10):3758-3769. PubMed ID: 29363574
[TBL] [Abstract][Full Text] [Related]
3. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.
Chen Z; Li S; Huang K; Zhang Q; Wang J; Li X; Hu T; Wang S; Yang R; Jia Y; Sun H; Tang F; Zhou H; Shen J; Ma D; Wang S
Hum Pathol; 2013 Oct; 44(10):2097-105. PubMed ID: 23791009
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow overexpression of SNAI1 is an early indicator of intrinsic drug resistance in patients with de novo acute myeloid leukemia.
Gouda MBY; Hassan NM; Kandil EI
J Gene Med; 2023 May; 25(5):e3443. PubMed ID: 35900907
[TBL] [Abstract][Full Text] [Related]
5. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
[TBL] [Abstract][Full Text] [Related]
6. Injury induces endothelial to mesenchymal transition in the mouse corneal endothelium in vivo via FGF2.
Lee J; Jung E; Heur M
Mol Vis; 2019; 25():22-34. PubMed ID: 30804659
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression.
Fang C; Zan J; Yue B; Liu C; He C; Yan D
J Gastroenterol Hepatol; 2017 Jun; 32(6):1204-1211. PubMed ID: 27862275
[TBL] [Abstract][Full Text] [Related]
8. SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue.
Peña C; García JM; Larriba MJ; Barderas R; Gómez I; Herrera M; García V; Silva J; Domínguez G; Rodríguez R; Cuevas J; de Herreros AG; Casal JI; Muñoz A; Bonilla F
Oncogene; 2009 Dec; 28(49):4375-85. PubMed ID: 19802011
[TBL] [Abstract][Full Text] [Related]
9. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
[TBL] [Abstract][Full Text] [Related]
10. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
[TBL] [Abstract][Full Text] [Related]
11. Effects of Laminins 332 and 411 on the Epithelial-Mesenchymal Status of Colorectal Cancer Cells.
Mal'tseva DV; Makarova YA; Raigorodskaya MP; Rodin SA
Bull Exp Biol Med; 2019 Jan; 166(3):377-382. PubMed ID: 30627897
[TBL] [Abstract][Full Text] [Related]
12. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
13. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
14. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
[TBL] [Abstract][Full Text] [Related]
15. The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1.
Carmichael CL; Wang J; Nguyen T; Kolawole O; Benyoucef A; De Mazière C; Milne AR; Samuel S; Gillinder K; Hediyeh-Zadeh S; Vo ANQ; Huang Y; Knezevic K; McInnes WRL; Shields BJ; Mitchell H; Ritchie ME; Lammens T; Lintermans B; Van Vlierberghe P; Wong NC; Haigh K; Thoms JAI; Toulmin E; Curtis DJ; Oxley EP; Dickins RA; Beck D; Perkins A; McCormack MP; Davis MJ; Berx G; Zuber J; Pimanda JE; Kile BT; Goossens S; Haigh JJ
Blood; 2020 Aug; 136(8):957-973. PubMed ID: 32369597
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cyst.
Chu CH; Chou W; Wang F; Yeh CN; Chen TC; Yeh TS
J Gastroenterol Hepatol; 2016 May; 31(5):1052-9. PubMed ID: 26479153
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue.
Mahdavinezhad A; Yadegarazari R; Mousavi-Bahar SH; Poorolajal J; Jafari M; Amirzargar MA; Effatpanah H; Saidijam M
Investig Clin Urol; 2017 Mar; 58(2):140-145. PubMed ID: 28261684
[TBL] [Abstract][Full Text] [Related]
18. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer.
Bronsert P; Kohler I; Timme S; Kiefer S; Werner M; Schilling O; Vashist Y; Makowiec F; Brabletz T; Hopt UT; Bausch D; Kulemann B; Keck T; Wellner UF
Surgery; 2014 Jul; 156(1):97-108. PubMed ID: 24929761
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.
Xavier PLP; Cordeiro YG; Rochetti AL; Sangalli JR; Zuccari DAPC; Silveira JC; Bressan FF; Fukumasu H
Vet Comp Oncol; 2018 Dec; 16(4):596-605. PubMed ID: 30047225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
